000 01471 a2200409 4500
005 20250515193131.0
264 0 _c20100205
008 201002s 0 0 eng d
022 _a1476-4598
024 7 _a10.1186/1476-4598-8-94
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBhuvaneswari, Ramaswamy
245 0 0 _aTargeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.
_h[electronic resource]
260 _bMolecular cancer
_cNov 2009
300 _a94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCetuximab
650 0 4 _aCombined Modality Therapy
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aPhotochemotherapy
650 0 4 _aRemission Induction
650 0 4 _aUrinary Bladder Neoplasms
_xdrug therapy
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aGan, Yik Yuen
700 1 _aSoo, Khee Chee
700 1 _aOlivo, Malini
773 0 _tMolecular cancer
_gvol. 8
_gp. 94
856 4 0 _uhttps://doi.org/10.1186/1476-4598-8-94
_zAvailable from publisher's website
999 _c19267302
_d19267302